Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Utah Medical Products Inc. (UTMD)
Market Closed
17 Jul, 20:00
NASDAQ (NGS)
All
(3)
DE
(2)
US
(1)
NASDAQ (NGS)
Primary
XFRA
XSTU
$
69.
80
-1.94
-2.7042%
$
217.31M
Market Cap
14.7
P/E Ratio
1.2%
Div Yield
14,000
Volume
0
Eps
$
71.74
Previous Close
Investors:
CE
SN
+10
Watching
Watch
Add Transaction
Day Range
69.01
71.48
Year Range
53.66
75.75
Want to track
UTMD
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Utah Medical Products Inc. (UTMD) Statistics
Valuation metrics
Market Cap
217.31M
Enterprise value
135.05M
Trailing P/E (ttm)
21.15
Forward P/E
-
PEG ratio
-1.76
Price/Sales (ttm)
5.92
Price/Book (mrq)
1.85
Enterprise Value/Revenue
3.6
Enterprise Value/EBITDA
8.25
Overview
Shares outstanding
-
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
13.61K
Average volume (90 days)
14.26K
Price summary
52-Week low
53.66
52-Week high
75.75
Beta
-
50-Day moving average
69.87
200-Day moving average
64.36
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
1.24
Trailing annual dividend yield
0.0177%
5-Year annual dividend yield
-
Payout ratio
0.36
Dividend Date
3 Jul 2026
Ex-Dividend Date
17 Jun 2026
Last split factor
3:2
Last split Date
22 Mar 1993
Financials
Fiscal year
Fiscal year ends
-
Most recent quarter (mrq)
-
Profitability
Profit margin
0.29%
Operating margin
0.29%
Operational effectiveness
Return on assets
0.09%
Return on equity
0.09%
Income Statement
Revenue (ttm)
-
Revenue per share (ttm)
11.78
Quarterly revenue growth (yoy)
-
Gross profit (ttm)
-
EBITDA
-
Net income to common (ttm)
-
Diluted EPS (ttm)
3.41
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
-
Total cash per share (mrq)
27.44
Total debt (mrq)
-
Total Debt/Equity (mrq)
0
Current ratio (mrq)
28.64%
Book value per share (mrq)
37.79
Cash Flow
Cash flow statement
-
Levered free cash flow (LFCF)
-